FBIOP
Price
$15.57
Change
+$0.22 (+1.43%)
Updated
Mar 1, 6:59 PM EST
NKTR
Price
$0.78
Change
+$0.07 (+9.86%)
Updated
Mar 1, 6:59 PM EST
One day until earnings call
Ad is loading...

Analysis and predictions FBIOP vs NKTR

Header iconFBIOP vs NKTR Comparison
Open Charts FBIOP vs NKTRBanner chart's image
Fortress Biotech
Price$15.57
Change+$0.22 (+1.43%)
Volume$5.63K
CapitalizationN/A
Nektar Therapeutics
Price$0.78
Change+$0.07 (+9.86%)
Volume$1.27M
CapitalizationN/A
View a ticker or compare two or three
FBIOP vs NKTR Comparison Chart

Loading...

FBIOPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NKTRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FBIOP vs. NKTR commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIOP is a Hold and NKTR is a Hold.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (FBIOP: $15.45 vs. NKTR: $0.78)
Brand notoriety: FBIOP: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIOP: 82% vs. NKTR: 156%
Market capitalization -- FBIOP: $0 vs. NKTR: $148.8M
FBIOP [@Biotechnology] is valued at $0. NKTR’s [@Biotechnology] market capitalization is $148.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIOP’s FA Score shows that 1 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • FBIOP’s FA Score: 1 green, 4 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIOP is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIOP’s TA Score shows that 3 TA indicator(s) are bullish while NKTR’s TA Score has 7 bullish TA indicator(s).

  • FBIOP’s TA Score: 3 bullish, 6 bearish.
  • NKTR’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than FBIOP.

Price Growth

FBIOP (@Biotechnology) experienced а +0.46% price change this week, while NKTR (@Biotechnology) price change was +14.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.24%. For the same industry, the average monthly price growth was +20.36%, and the average quarterly price growth was +48.76%.

Reported Earning Dates

NKTR is expected to report earnings on May 08, 2024.

Industries' Descriptions

@Biotechnology (+7.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FBIOP with price predictions.
OPEN
A.I.dvisor published
a Summary for NKTR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NKTR YTD gains are higher at: 38.053 vs. FBIOP (33.878). FBIOP has higher annual earnings (EBITDA): -159.65M vs. NKTR (-255.68M). NKTR has more cash in the bank: 373M vs. FBIOP (99.5M). FBIOP has less debt than NKTR: FBIOP (70.1M) vs NKTR (121M). NKTR has higher revenues than FBIOP: NKTR (88.3M) vs FBIOP (81M).
FBIOPNKTRFBIOP / NKTR
CapitalizationN/A149M-
EBITDA-159.65M-255.68M62%
Gain YTD33.87838.05389%
P/E RatioN/AN/A-
Revenue81M88.3M92%
Total Cash99.5M373M27%
Total Debt70.1M121M58%
FUNDAMENTALS RATINGS
FBIOP vs NKTR: Fundamental Ratings
FBIOP
NKTR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
60100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3937
P/E GROWTH RATING
1..100
10083
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIOP's Valuation (1) in the null industry is somewhat better than the same rating for NKTR (53) in the Biotechnology industry. This means that FBIOP’s stock grew somewhat faster than NKTR’s over the last 12 months.

FBIOP's Profit vs Risk Rating (60) in the null industry is somewhat better than the same rating for NKTR (100) in the Biotechnology industry. This means that FBIOP’s stock grew somewhat faster than NKTR’s over the last 12 months.

NKTR's SMR Rating (98) in the Biotechnology industry is in the same range as FBIOP (100) in the null industry. This means that NKTR’s stock grew similarly to FBIOP’s over the last 12 months.

NKTR's Price Growth Rating (37) in the Biotechnology industry is in the same range as FBIOP (39) in the null industry. This means that NKTR’s stock grew similarly to FBIOP’s over the last 12 months.

NKTR's P/E Growth Rating (83) in the Biotechnology industry is in the same range as FBIOP (100) in the null industry. This means that NKTR’s stock grew similarly to FBIOP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPNKTR
RSI
ODDS (%)
Bearish Trend 3 days ago
37%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
49%
Bullish Trend 3 days ago
71%
Momentum
ODDS (%)
Bearish Trend 3 days ago
50%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 7 days ago
56%
Bullish Trend 21 days ago
74%
Declines
ODDS (%)
Bearish Trend 13 days ago
49%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Ad is loading...
FBIOPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NKTRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTGX32.151.77
+5.83%
Protagonist Therapeutics
RRC32.140.52
+1.64%
Range Resources Corp
PARAP14.47-0.03
-0.21%
Paramount Global
HAFC15.01-0.10
-0.66%
Hanmi Financial Corp
ATRA0.77-0.01
-0.94%
Atara Biotherapeutics

FBIOP and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIOP has been loosely correlated with ARAV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIOP jumps, then ARAV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIOP
1D Price
Change %
FBIOP100%
+0.74%
ARAV - FBIOP
45%
Loosely correlated
N/A
EVGN - FBIOP
26%
Poorly correlated
+7.55%
NKTR - FBIOP
25%
Poorly correlated
+9.86%
ZLAB - FBIOP
23%
Poorly correlated
+0.57%
ASND - FBIOP
23%
Poorly correlated
+3.19%
More